"We firmly appreciate the importance of maintaining presence in the regions alongside the value and access players. Therefore, we have decided to go for a complete…
In Conversation
Alba Ancochea of FEDER, the association that groups together Spain’s 337 rare disease patient organizations, explains how it interacts with both government and industry to the…
The AGP feels that the patient should have access to information, so the alliance strives to accommodate this
"We’ve actually entered an unprecedented phase for the company, having launched more products in the past four years than in the entire decade before"
"While we may not yet be feeling the effects of falsified medicines right now in Spain, I think that, if mitigating steps are not taken, then…
"In Spain, it is widely perceived that the hospitals are stuck in their mindset because although we have some of the best healthcare institutes in the…
"In Spain, there is a huge opportunity ahead of us in terms of penetration of both generics and biosimilars"
"Spain is a natural place for us to be"
"Big data is the main opportunity that the healthcare sector can capitalize on in Spain, with this possibility increasing the productivity of the healthcare sector. The…
"Although Azierta is well grounded in Spain, and almost 20 percent of our business is coming from Europe, we are in the initial stages of expansion,…
"We have become pioneers in Spain’s tourism sector by launching a 5G environment, which opens up the option to host virtual fairs. This innovative idea was…
"Big hurdles in the reimbursement process are also the 17 autonomous health systems as well as the hospitals. Even if the regions approve the drug and…
